Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee...
-
Upload
marilynn-reed -
Category
Documents
-
view
220 -
download
0
Transcript of Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee...
![Page 1: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/1.jpg)
Overview of EMCDDA’s Scientific Work
Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008
![Page 2: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/2.jpg)
Objective of this presentation
• Provide you with a overview of the scientific work at the EMCDDA so that we share a common understanding of how we have got to this particular point in our development, and why our current work programme looks like it does
• Apologies to those who know us well already…
![Page 3: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/3.jpg)
More concretely
• Historical, structural & external factors that shape our work
• Organisation & working practices• Overview of current areas of work• Show how these are manifest in the current 3 year
and 2008 Work programmes• Overview a few of the forthcoming outputs that may
be of interest
![Page 4: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/4.jpg)
First… a few things to remember that are obvious but easy to forget…
• We work at the European level• We are not a research institute • We work at the interface between policy, practice, and
science which can be a difficult place to be!• As an information centre our credibility is dependent on
produce independent, methodologically sound and scientifically rigorous analysis
• Scientific Committee is likely to play an increasingly important role in ensuring this
![Page 5: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/5.jpg)
Historical, structural & external factors shaping our work – the context
![Page 6: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/6.jpg)
Historical
• Information collection ongoing for around 12 years during this period emphasis has been on capacity building, instrument development and standardisation
• Developed based at first on existing areas of work & reflected concerns of the day
• Move from externalised to internalised activities• Move from epidemiology to interventions• Move from demand to supply
![Page 7: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/7.jpg)
Structural & external factors
• Founding regulation basis for work• Commitment to annual reporting • Recast to regulation in 2007 gave more emphasis
• New trends• Identification and dissemination of best practice• Poly-drug use including combined use licit & illicit
substances• Supply information has always been collected but need to scale-
up activities• EU – drug strategy and action plan(s) have become increasingly
important • EU Enlargement remains an important factor
![Page 8: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/8.jpg)
EMCDDA’s contribution to current Action Plan (2005-2008)
• Ongoing work of EMCDDA informs assessment drug situation
• Drafting of thematic papers (coordination, drug demand reduction and information/research/evaluation)
• Preparation of a snapshot on the drug situation in the EU 2004-2008
• Helped to define the assessment tools/indicators for the Action Plan
![Page 9: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/9.jpg)
Challenges of working in a growing family
• Currently reporting • All EU member states• Norway by special arrangement• Candidate countries - Croatia & Turkey
• The Russian Federation and Ukraine have growing interest in EMCDDA work
• The needs of countries and reporting ability varies considerably
• Quality control and the analysis of data can raise political as well as scientific issues
![Page 10: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/10.jpg)
Organisation of the work
![Page 11: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/11.jpg)
Director
Reitox and international cooperation
Epidemiology, crime and markets
Interventions, law and policies
Scientific partners and documentation
Communication
ICT
Administration
Scientific Coordination
In-house structure
![Page 12: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/12.jpg)
Director
Reitox and international cooperation
Epidemiology, crime and markets
Interventions, law and policies
Scientific partners and documentation
Communication
ICT
Administration
Scientific Coordination
In-house structure
![Page 13: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/13.jpg)
Director
Reitox and international cooperation
EPI
RES
Scientific partners and documentation
Communication
ICT
Administration
Scientific Coordination
In-house structure
![Page 14: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/14.jpg)
Resources - scientific staff – EPI / RES
• Two Head of Units • 24 Scientific analysts coming from sociology,
psychology, medicine, law, economics, biology … • 6 Data managers / project assistance• 4 Secretaries• Occasional stagiaires etc...
![Page 15: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/15.jpg)
Data Collection• Annual reporting exercise• Main data provider is the network of national focal points
(Reitox)• Common methods and reporting tools (in online
interface)• National reports (contextual & text based) • Standard tables (quantitative data – reporting cycle
annual)• Structured questionnaires (more qualitative / reporting
cycle more flexible) • Supported by standing technical working groups, ad hoc
meetings and studies
![Page 16: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/16.jpg)
The Units
• EPI • RES
![Page 17: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/17.jpg)
Current areas of interest
• Drug situation
• Patterns and scale of use
• Public health impact
• Crime and Interdiction statistics
• Drug Market information
• Price
• Purity
• Identification new trends & threats
• Policies developments• Legal developments• Responses
• Prevention • Treatment• Harm reduction• Supply reduction
• Interdiction practice• Economic modelling
![Page 18: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/18.jpg)
Challenges
• More heterogeneous drug situation • Improved classification of drug use patterns• More integrated approach to treatment • Integration of supply and demand data• Improving the timeliness of our data
![Page 19: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/19.jpg)
Monitoring tools - Epidemiology
• 5 key indicators (politically endorsed in EUAP)• Prevalence & patterns of drug use• Prevalence & patterns of problem drug use• Drug-related infectious diseases (HIV, HCV, HBV)• Drug-related deaths and mortality of drug users• Demand for drug treatment
• Core data • Drug law offences and market information• Youth prevalence and patterns of drug use + ESPAD• Joint Action on New Synthetic Drugs EWS
![Page 20: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/20.jpg)
LMP of cannabis among 15-64, 15-34, 15-24
%
2%
4%
6%
8%
10%
12%
14%
16%
18%
20%
SE
(20
06)
LT (
2004
)
BG
(20
05)
EL
(200
4)
PL
(200
2)
EE
(20
03)
HU
(20
03)
CY
(20
06)
FI (
2004
)
SK
(20
04)
LV (
2003
)
NO
(20
04)
PT
(20
01)
DK
(20
05)
IE (
2002
/03)
BE
(20
04)
NL
(200
5)
DE
(20
03)
AT
(20
04)
LU (
1998
)
CZ
(20
04)
FR
(20
05)
UK
(E
&W
) (2
005/
06)
IT (
2005
)
ES
(20
05/0
6)
A ll adults
Young adults (15-34 y.)
Younger adults (15 to 24 y.)
![Page 21: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/21.jpg)
Estimated number of new clients entering treatment by primary drug used
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
1999 2000 2001 2002 2003 2004 2005
nu
mb
er
Heroin
Cocaine
Cannabis
Other Stimulants
Other drugs
![Page 22: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/22.jpg)
Indexed trends in reports for drug law offences in EU MS 2000-2005
136
162
147
85
60
100
140
180
2000 2001 2002 2003 2004 2005
All reports
Cannabis
Heroin
Cocaine
![Page 23: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/23.jpg)
Monitoring tools – Strategies, laws and responses
• Support for EU strategy and Action plan on drugs and cooperation at the European level
• Monitoring laws, policies and strategies• Relevant to transversal analyse: cost studies, policy
evaluation… • Responses
• Prevention • Treatment • Harm Reduction
• Identification and dissemination of best practice
![Page 24: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/24.jpg)
Year of introduction of MMT and HDB treatment in 26 EU MS and Norway
0
5
10
15
20
25
30
1965 1970 1975 1980 1985 1990 1995 2000 2005
Cu
mu
lati
ve n
um
ber
of
cou
ntr
ies
pro
vid
ing
MM
T a
nd
HD
BT
Methadone maintenance
high dosage buprenorphine
![Page 25: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/25.jpg)
Estimated number of clients receiving opioid substitution
treatment in EU-15, 1993-2005
0
100000
200000
300000
400000
500000
600000
700000
1993 1995 1997/1998 2001/2002 2003 2005
Cli
en
ts i
n s
ub
sti
tuti
on
45% of problem opiate user in EU
![Page 26: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/26.jpg)
EMCDDA – best practices - the portal
• The EMCDDA is developing a best practices portal• will provide an overview on the latest evidence on
the effectiveness of interventions (prevention, treatment, social reintegration, harm reduction)
• present tools and standards aimed at improving the quality of interventions
• highlight best-practice examples from the field• Primarily aimed at professionals, policy-makers and
researchers• Collaboration: Cochrane, SANCO, UNODC
![Page 27: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/27.jpg)
![Page 28: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/28.jpg)
The Work Programme
![Page 29: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/29.jpg)
Triennial and annual work plans
• Three year work-plan and strategy (2006-2009) is implemented through three annual work plans
• The Scientific Committee provides the MB with an opinion on triennial and annual work- plans
![Page 30: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/30.jpg)
The 3 Year Work programme - priorities
• Consolidate monitoring and reporting activities
• Enhancing analysis of data
• Communicate effectively with target audiences
• rationalisation and review reporting tools
• focus given to core reporting areas
• Improved tools (Fonte)• More emphasis on
technical assistance quality control & standards
![Page 31: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/31.jpg)
The 3 Year Work programme - priorities
• Consolidate monitoring and reporting activities
• Enhancing analysis of data
• Communicate effectively with target audiences
• Moving beyond simple description
• Better exploitation of historical data
• More transversal analysis
• Better integration with scientific literature and research
![Page 32: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/32.jpg)
The 3 Year Work programme - priorities
• Consolidate monitoring and reporting activities
• Enhancing analysis of data
• Communicate effectively with target audiences
• New communications strategy
• Better demarcation of products
• More output focussed• More emphasis given to
scientific publishing
![Page 33: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/33.jpg)
2008 Work Programme
Breaks down the 3-year programme into annual activities and products, e.g.
• Analysis of trends: long- and medium-term trends in drug use in Europe (evaluation of the EUAP, UNGASS evaluation)
• Increase emphasis on best practice and analysis of the extent to which European responses meet estimated needs
• Developing a strategy for supply• Treatment and poly-drugs use working group
![Page 34: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/34.jpg)
2008 Work Programme
EMCDDA Scientific Monograph • Release of the Cannabis monograph• Preparatory work on Harm reduction Monograph
EMCDDA Manuals • Update of KI protocols: TDI, DRD
Drug profiles • Benzodiazepines, Piperazines….
EMCDDA Insights • Assessing illicit drug use in wastewater
Drugs in focus – policy briefings• Drug use and old age – a new problem• Cocaine and heroin trafficking in Europe…
![Page 35: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/35.jpg)
In summary
The 3 year WP and 2008 WP are intended to meet the needs:• To consolidate and rationalise the data collection process
• To use and analyse the information collected more efficiently
• To improve the monitoring of new developments
• To continue developing new areas:
• supply issues
• economic analysis
• best practices
• cross indicator analysis, etc...
• To better tailor EMCDDA products to different audiences
• To further improve collaboration with scientific community
• To continue and reinforce international and technical cooperation
![Page 36: Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.](https://reader035.fdocuments.in/reader035/viewer/2022062314/56649efa5503460f94c0cca5/html5/thumbnails/36.jpg)
Concluding remarks
What we would like to get from this ScC …